Internal Medicine · Abbeville, LA
NPI
1487768214
Since 2006
Specialty
Internal Medicine
Code 207R00000X
Group practices
3
Medicare group memberships
Hospitals
4
Hospital affiliations
2621 North Dr Ste B
Abbeville, LA, 70510
Phone (337) 898-1860
Groups this clinician bills Medicare through
Medicare paid, 2024
$294K
5,720 services
Medicare patients, 2024
896
Average age 77
Drug cost, 2024
$2.6M
46,715 prescriptions
Company payments, 2025
$1,522
From 17 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Ronald M Lahasky was code 99214 (office e&m - established), 1,065 times for 596 patients. In total Ronald M Lahasky billed 5,720 services in 44 codes, and Medicare paid $294K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2012-08-06.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 1,065 | 596 | $75.92 | $81K |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 836 | 141 | $0.07 | $56.77 |
| 99213 Office E&M - Established | Office | 749 | 365 | $53.36 | $40K |
| 99497 Care Management/Coordination | Office | 517 | 517 | $76.25 | $39K |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 517 | 517 | $119.87 | $62K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 436 | 384 | $11.35 | $4,947 |
| 93010 Electrocardiogram | Facility | 261 | 219 | $5.87 | $1,531 |
| 96372 Injection Administration | Office | 230 | 156 | $8.03 | $1,848 |
| 99231 Hospital E&M - Subsequent | Facility | 229 | 73 | $35.71 | $8,177 |
| G0008 Administration of influenza virus vaccine | Office | 135 | 134 | $30.16 | $4,072 |
| 90658 Vaccine Product | Office | 130 | 130 | $21.42 | $2,785 |
| 99238 Hospital Discharge Management | Facility | 110 | 88 | $58.96 | $6,485 |
| 99222 Hospital E&M - Initial | Facility | 73 | 61 | $92.24 | $6,734 |
| G0179 Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians a | Office | 66 | 32 | $27.69 | $1,828 |
| 99496 Chronic, Principal, and Transitional Care Management | Office | 63 | 56 | $202.18 | $13K |
By year: 2022 $146K for 5,634 services; 2023 $314K for 5,694 services; 2024 $294K for 5,720 services.
Medicare prescription drug claims, 2024
In 2024, the drug Ronald M Lahasky prescribed most often to Medicare patients was Furosemide, with 1,594 prescriptions and refills. In total Ronald M Lahasky wrote 46,715 Medicare prescriptions that cost $2.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Furosemide Generic | 1,594 | 2,064 | 267 | $7,817 |
| Levothyroxine Sodium Generic | 1,566 | 2,193 | 222 | $17K |
| Amlodipine Besylate Generic | 1,222 | 1,744 | 210 | $8,222 |
| Pantoprazole Sodium Generic | 1,192 | 1,623 | 203 | $15K |
| Atorvastatin Calcium Generic | 1,181 | 1,603 | 185 | $13K |
| Potassium Chloride Generic | 1,001 | 1,166 | 154 | $18K |
| Gabapentin Generic | 981 | 1,179 | 145 | $13K |
| Simvastatin Generic | 919 | 1,754 | 184 | $4,973 |
| Meloxicam Generic | 883 | 1,229 | 163 | $3,214 |
| Eliquis Apixaban | 824 | 862 | 72 | $279K |
| Lisinopril Generic | 796 | 1,224 | 148 | $4,803 |
| Sertraline Hcl Generic | 776 | 933 | 105 | $7,019 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 718 | 719 | 93 | $13K |
| Donepezil Hcl Generic | 716 | 840 | 106 | $7,589 |
| Metformin Hcl Generic | 714 | 1,159 | 135 | $4,535 |
Brand drugs: 6,143 claims; generic drugs: 40,244 claims; opioid claims: 1,704.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Ronald M Lahasky $1,522 ($1,522 in general payments such as food, travel and fees) from 17 companies. The largest payer was Amgen Inc. with $294.
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. AMGN | 16 | $294 |
| Novo Nordisk Inc NVO | 11 | $167 |
| AstraZeneca Pharmaceuticals LP AZN | 10 | $163 |
| Axsome Therapeutics, Inc. AXSM | 5 | $126 |
| Exact Sciences Corporation EXAS | 6 | $123 |
| Otsuka America Pharmaceutical, Inc. 4578.T | 5 | $116 |
| Ardelyx, Inc. ARDX | 4 | $86.62 |
| Lundbeck LLC | 4 | $83.01 |
| Lilly USA, LLC LLY | 5 | $82.32 |
| Phathom Pharmaceuticals, Inc. PHAT | 5 | $61.43 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.